REPROGRAMACIÓN Y REGENERACIÓN NEURAL
Massachusetts General Hospital
Boston, Estados UnidosPublicaciones en colaboración con investigadores/as de Massachusetts General Hospital (7)
2008
-
Enhanced binding of metabotropic glutamate receptor type 5 (mGluR5) PET tracers in the brain of parkinsonian primates
NeuroImage, Vol. 42, Núm. 1, pp. 248-251
2007
-
In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias
Neurobiology of Disease, Vol. 27, Núm. 2, pp. 220-227
2005
-
Insights into Parkinson's disease models and neurotoxicity using non-invasive imaging
Toxicology and Applied Pharmacology
2004
-
Mapping dopamine function in primates using pharmacologic magnetic resonance imaging
Journal of Neuroscience, Vol. 24, Núm. 43, pp. 9553-9560
-
Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease
Journal of Neuroinflammation, Vol. 1
2003
-
Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model
NeuroImage, Vol. 20, Núm. 2, pp. 1064-1075
2002
-
Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model
Proceedings of the National Academy of Sciences of the United States of America, Vol. 99, Núm. 4, pp. 2344-2349